Wy. Zhu et al., Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells, CANCER RES, 59(1), 1999, pp. 85-90
Treatment of estrogen receptor (ER)-positive MCF-7 human breast cancer cell
s with retinoic acid (RA) inhibited cell growth and increased cell adhesion
to fibronectin. In contrast, ER- MDA-MB-231 cells failed to respond. Weste
rn blot analysis showed that tyrosine phosphorylation of two major bands at
M-r 125,000 and M-r 68,000 was induced by RA in ER+ MCF-7 human breast car
cinoma cells. However, this induction was a late phenomenon detectable at 1
2 and 24 h, but not within 3 h, A similar increase of tyrosine phosphorylat
ion by RA was observed in ER+ human breast cancer cell lines T-47D and ZR-7
5-1, but not in the ER- cell lines MDA-MB-231, MDA-MB-453, and MDA-MB-468.
Focal adhesion kinase and paxillin, which localize in focal adhesion plaque
s and may play important roles in the integrin signaling pathway, were iden
tified as the major proteins showing IU-induced tyrosine phosphorylation. T
he retinoid X receptor-selective compound SR11237 failed to induce tyrosine
phosphorylation, indicating that retinoid X receptor activation is not inv
olved in this phenomenon. In contrast, stable overexpression of a truncated
RA receptor (RAR) alpha cDNA, RAR alpha 403, with strong RAR dominant nega
tive activity prevented the increase in tyrosine phosphate, suggesting that
RAR signaling is involved in RA-induced tyrosine phosphorylation. Tyrosine
phosphorylation was induced the most by the RAR-alpha (193836), followed b
y RAR-gamma (194433), but was not significantly induced by RAR-beta (193174
)-selective retinoids, This study demonstrates a coordinated albeit relativ
ely late effect of RA on cell adhesion and tyrosine phosphorylation in ERhuman breast cancer cells and suggests RAR-alpha as the major responsible r
etinoid receptor.